Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Corcept Therapeutics Inc.

CORT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CORT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
CORT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CORT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CORT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CORT holdings by institutional investors

Quarterly net insider trading by CORT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for CORT

Quiver Logo

No former government officials on record as having lobbied for CORT

Revolving Door Dashboard

CORT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CORT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CORT Income Statement
CORT Balance Sheet
CORT Cash Flow
U.S. Patents

New CORT patent grants

  • Patent Title: Pyrylium method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators Sep. 15, 2026
  • Patent Title: Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency Jul. 28, 2026
  • Patent Title: Treatment of adrenocortical carcinoma with selective glucocorticoid receptor modulators (sgrms) and antibody checkpoint inhibitors Jun. 09, 2026
  • Patent Title: Treatment of, and differential diagnosis between, acth-dependent cushing's syndrome and acth-independent cushing's syndrome May. 12, 2026
  • Patent Title: Methods for reducing liver fat and for treating fatty liver disorders May. 05, 2026
  • Patent Title: Concomitant administration of glucocorticoid receptor modulator relacorilant and cyp2c9 substrates May. 05, 2026
  • Patent Title: Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of cyp2c8 and cyp3a4 Mar. 31, 2026
  • Patent Title: Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound Jan. 06, 2026
  • Patent Title: Method of normalizing the neutrophil to lymphocyte ratio in cancer patients with a selective glucocorticoid receptor antagonist Oct. 14, 2025
  • Patent Title: Treatments for amyotrophic lateral sclerosis using dazucorilant Oct. 07, 2025
  • Patent Title: Formulations of dazucorilant, a glucocorticoid receptor modulator Jul. 29, 2025
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer Jul. 29, 2025
  • Patent Title: Methods for shrinking pituitary tumors Jun. 24, 2025
  • Patent Title: Methods for imaging and treatment of somatostatin-receptor positive tumors May. 06, 2025
  • Patent Title: Glucocorticoid receptor modulators to treat cervical cancer Apr. 29, 2025
  • Patent Title: Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators Apr. 01, 2025
  • Patent Title: Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists Feb. 18, 2025
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Feb. 18, 2025
  • Patent Title: Quaternary indazole glucocorticoid receptor antagonists Dec. 31, 2024
  • Patent Title: Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors Dec. 24, 2024
  • Patent Title: Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Nov. 26, 2024
  • Patent Title: Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators Nov. 19, 2024
  • Patent Title: Systems and methods of treatment using intervention and tasking determination Jun. 12, 2018
  • Patent Title: Systems and methods of managing treatment of a chronic condition by symptom tracking May. 22, 2018
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators May. 01, 2018
  • Patent Title: Optimizing mifepristone levels for cushing's patients Apr. 17, 2018
  • Patent Title: Glucocorticoid receptor modulators to treat pancreatic cancer Apr. 17, 2018
  • Patent Title: Method for differentially diagnosing acth-dependent cushing's syndrome Nov. 28, 2017
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Jul. 18, 2017
  • Patent Title: Pyrimidine cyclohexyl glucocorticoid receptor modulators Apr. 26, 2016
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Mar. 01, 2016
  • Patent Title: Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists Dec. 30, 2014
  • Patent Title: Pyrimidine cyclohexyl glucocorticoid receptor modulators Dec. 09, 2014
  • Patent Title: Solid forms and process for preparing Nov. 18, 2014
  • Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators Oct. 14, 2014
  • Patent Title: Combination steroid and glucocorticoid receptor antagonist therapy Sep. 09, 2014
  • Patent Title: Antiglucocorticoid therapy for the prevention of neurological damage in premature infants Jun. 03, 2014
  • Patent Title: Pyrimidine cyclohexyl glucocorticoid receptor modulators Apr. 01, 2014
  • Patent Title: Pyridyl-amine fused azadecalin modulators Dec. 03, 2013
  • Patent Title: Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists Dec. 03, 2013
  • Patent Title: Fused ring azadecalin glucocorticoid receptor modulators Oct. 15, 2013
  • Patent Title: Methods for treating psychosis associated with interferson-α therapy Jul. 02, 2013
  • Patent Title: Solid forms and process for preparing Jun. 11, 2013
  • Patent Title: Methods for treating migraine May. 28, 2013
  • Patent Title: Azadecalin glucocorticoid receptor modulators Dec. 04, 2012
  • Patent Title: Modified pyrimidine glucocorticoid receptor modulators May. 08, 2012
  • Patent Title: Antiglucocorticoids for the treatment of catatonia Jan. 17, 2012
  • Patent Title: Fused ring azadecalin glucocorticoid receptor modulators Apr. 19, 2011
  • Patent Title: Methods for treating delirium using glucocorticoid receptor-specific antagonists Feb. 08, 2011
  • Patent Title: Azadecalin glucocorticoid receptor modulators Mar. 16, 2010
Government Contracts

Estimated quarterly amount awarded to CORT from public contracts

CORT News

Recent insights relating to CORT

CNBC Recommendations

Recent picks made for CORT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CORT

CORT Analyst Ratings

CORT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CORT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CORT stock a Buy, Sell, or Hold?

  • What is the price target for $CORT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CORT Top Shareholders
Shareholder
Shares Held
CORT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CORT stock?

  • Who owns the most shares of $CORT stock?

  • What funds own $CORT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CORT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CORT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CORT

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

  • Address Redwood City, CA
  • Market Cap 12.2 billion
  • Employees 730
  • Industrial Classification Pharmaceutical Preparations

Corcept Therapeutics Inc. (CORT) Historical Stock Prices

Corcept Therapeutics Inc. (CORT) closed at $112.94 on September 23, 2026. Over the past year its adjusted close ranged from $32.15 to $123.57. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month-8.36%
  • 3 months+38.47%
  • Year to date+224.54%
  • 1 year+35.55%
  • 3 years+256.95%
  • 5 years+456.63%
  • Max+3,251.34%
See every congressional and insider trade on the CORT price chart

Quiver Premium charts CORT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 117.33 118.79 112.05 112.94 112.94 809,873
Sep 22, 2026 113.96 119.00 113.09 117.50 117.50 810,249
Sep 21, 2026 110.29 116.65 109.00 113.76 113.76 1,346,986
Sep 18, 2026 116.80 117.90 108.41 110.29 110.29 17,233,443
Sep 17, 2026 113.18 115.09 111.07 114.86 114.86 883,643
Sep 16, 2026 110.82 113.60 110.49 111.81 111.81 668,642
Sep 15, 2026 111.97 112.80 109.40 110.82 110.82 1,458,661
Sep 14, 2026 113.38 114.52 111.10 111.80 111.80 1,230,701
Sep 11, 2026 115.22 117.84 109.30 112.79 112.79 1,282,453
Sep 10, 2026 114.42 116.99 113.20 114.92 114.92 683,007
Sep 9, 2026 114.20 117.50 113.77 115.70 115.70 572,048
Sep 8, 2026 108.87 115.28 108.25 113.98 113.98 1,045,845
Sep 4, 2026 110.59 112.13 109.26 111.62 111.62 604,556
Sep 3, 2026 110.38 114.61 109.43 112.80 112.80 611,214
Sep 2, 2026 113.38 115.78 108.72 110.43 110.43 960,829
Sep 1, 2026 113.92 115.85 111.13 113.38 113.38 1,112,265
Aug 31, 2026 113.64 114.53 111.23 113.35 113.35 636,565
Aug 28, 2026 117.14 118.67 112.97 113.88 113.88 917,931
Aug 27, 2026 119.25 121.30 116.70 116.93 116.93 642,409
Aug 26, 2026 122.57 123.64 119.74 119.80 119.80 981,085
Aug 25, 2026 124.89 126.38 122.00 123.57 123.57 981,693
Aug 24, 2026 120.56 124.14 119.17 123.24 123.24 1,012,861
Aug 21, 2026 121.48 123.44 120.56 122.25 122.25 656,444
Aug 20, 2026 118.11 121.72 116.31 121.05 121.05 787,410
Aug 19, 2026 119.37 121.11 118.37 119.02 119.02 859,696
Aug 18, 2026 116.59 119.95 116.59 118.10 118.10 804,025
Aug 17, 2026 115.00 117.49 114.39 117.17 117.17 541,103
Aug 14, 2026 110.61 114.90 110.08 114.47 114.47 728,923
Aug 13, 2026 112.53 113.00 110.23 110.51 110.51 740,456
Aug 12, 2026 110.89 114.00 110.60 112.18 112.18 662,994
Aug 11, 2026 114.13 114.71 111.66 111.86 111.86 699,950
Aug 10, 2026 110.84 114.63 110.05 114.23 114.23 1,256,088
Aug 7, 2026 108.25 110.79 108.08 110.77 110.77 769,042
Aug 6, 2026 111.00 111.00 107.32 107.95 107.95 761,834
Aug 5, 2026 111.00 111.96 109.21 110.69 110.69 846,859
Aug 4, 2026 113.00 113.45 109.03 109.80 109.80 1,266,014
Aug 3, 2026 114.16 115.00 109.00 112.80 112.80 1,688,643
Jul 31, 2026 118.11 118.53 111.79 114.49 114.49 1,841,241
Jul 30, 2026 112.00 122.21 104.75 118.32 118.32 4,498,077
Jul 29, 2026 94.84 96.60 91.54 92.95 92.95 1,550,636
Jul 28, 2026 90.89 94.32 90.00 94.19 94.19 823,417
Jul 27, 2026 91.59 93.35 90.12 91.12 91.12 1,418,901
Jul 24, 2026 96.76 97.63 94.57 95.36 95.36 1,003,983
Jul 23, 2026 90.97 97.05 90.43 96.66 96.66 981,135
Jul 22, 2026 95.18 95.65 90.77 90.88 90.88 1,378,260
Jul 21, 2026 92.00 95.79 91.21 95.65 95.65 839,334
Jul 20, 2026 90.84 92.66 90.07 91.57 91.57 1,612,079
Jul 17, 2026 88.50 91.45 87.22 90.52 90.52 1,893,054
Jul 16, 2026 89.69 92.64 88.86 89.72 89.72 878,106
Jul 15, 2026 90.30 90.45 86.14 89.57 89.57 1,019,944
Jul 14, 2026 86.40 90.96 85.61 90.47 90.47 1,159,606
Jul 13, 2026 90.30 91.49 84.88 85.90 85.90 1,325,305
Jul 10, 2026 92.65 93.17 90.02 91.88 91.88 1,128,600
Jul 9, 2026 92.21 95.11 91.91 93.25 93.25 1,189,339
Jul 8, 2026 92.76 94.68 91.17 92.94 92.94 1,037,212
Jul 7, 2026 92.35 94.77 92.21 94.04 94.04 1,142,046
Jul 6, 2026 90.29 92.83 89.73 91.61 91.61 1,171,754
Jul 2, 2026 90.30 90.30 86.82 90.21 90.21 772,001
Jul 1, 2026 87.07 91.00 86.04 88.48 88.48 1,046,617
Jun 30, 2026 87.61 89.10 86.38 86.95 86.95 738,687
Jun 29, 2026 87.44 89.23 86.58 87.89 87.89 864,938
Jun 26, 2026 83.72 87.49 82.31 87.32 87.32 1,591,004
Jun 25, 2026 81.89 87.47 80.12 84.75 84.75 1,103,059
Jun 24, 2026 80.56 81.89 80.02 81.56 81.56 754,151
Jun 23, 2026 80.03 82.31 79.22 79.85 79.85 947,293
Jun 22, 2026 80.70 82.00 77.38 79.71 79.71 882,897
Jun 18, 2026 82.82 83.30 79.40 79.91 79.91 1,875,597
Jun 17, 2026 84.25 85.40 81.45 81.75 81.75 850,651
Jun 16, 2026 83.18 84.27 82.13 83.71 83.71 767,927
Jun 15, 2026 82.91 83.68 79.40 83.12 83.12 1,043,279
Jun 12, 2026 82.91 84.79 82.40 82.91 82.91 719,110
Jun 11, 2026 79.01 84.17 78.50 83.25 83.25 1,094,144
Jun 10, 2026 76.61 81.91 76.52 78.12 78.12 1,494,455
Jun 9, 2026 73.96 77.62 73.62 77.49 77.49 1,010,542
Jun 8, 2026 72.88 75.65 72.62 73.33 73.33 867,422
Jun 5, 2026 74.77 75.09 72.58 72.62 72.62 774,689
Jun 4, 2026 72.79 75.43 72.29 74.89 74.89 910,093
Jun 3, 2026 70.93 72.94 70.07 72.65 72.65 793,392
Jun 2, 2026 70.00 71.53 68.84 71.20 71.20 984,675
Jun 1, 2026 69.29 71.11 68.25 70.44 70.44 1,097,203
May 29, 2026 68.57 69.62 68.04 69.49 69.49 775,040
May 28, 2026 66.72 69.90 65.64 68.38 68.38 1,190,047
May 27, 2026 64.70 66.74 63.92 66.65 66.65 1,891,018
May 26, 2026 60.36 60.80 59.03 60.36 60.36 681,815
May 22, 2026 60.00 60.95 59.54 60.22 60.22 536,139
May 21, 2026 58.48 59.96 57.72 59.69 59.69 874,622
May 20, 2026 58.64 59.55 57.10 59.06 59.06 1,115,257
May 19, 2026 55.04 58.45 54.59 58.22 58.22 1,498,409
May 18, 2026 56.49 56.77 55.00 55.12 55.12 816,451
May 15, 2026 57.44 57.88 56.09 56.37 56.37 874,662
May 14, 2026 57.38 59.20 56.18 58.30 58.30 1,879,134
May 13, 2026 53.84 57.98 53.30 57.08 57.08 2,307,963
May 12, 2026 51.15 51.50 50.60 51.16 51.16 771,282
May 11, 2026 52.92 52.98 51.11 51.20 51.20 1,325,132
May 8, 2026 51.05 52.48 50.32 52.28 52.28 872,697
May 7, 2026 52.03 52.62 49.83 51.05 51.05 1,117,279
May 6, 2026 51.69 52.98 51.00 52.15 52.15 1,534,564
May 5, 2026 52.16 52.16 51.00 51.33 51.33 1,176,334
May 4, 2026 51.38 52.50 50.16 51.60 51.60 1,388,637
May 1, 2026 48.48 51.66 46.19 51.42 51.42 3,274,664
Apr 30, 2026 46.97 47.24 45.73 46.52 46.52 1,233,101
Apr 29, 2026 46.21 47.29 46.20 46.59 46.59 1,235,735
Apr 28, 2026 46.22 47.09 45.98 46.62 46.62 725,190
Apr 27, 2026 46.22 47.00 45.70 46.22 46.22 646,806
Apr 24, 2026 45.91 46.43 44.58 46.06 46.06 632,812
Apr 23, 2026 46.35 46.98 44.24 45.08 45.08 881,455
Apr 22, 2026 45.64 46.63 45.01 46.57 46.57 727,190
Apr 21, 2026 46.39 46.68 44.50 45.10 45.10 961,880
Apr 20, 2026 45.88 46.60 45.06 46.34 46.34 722,709
Apr 17, 2026 44.54 46.56 44.54 46.16 46.16 1,734,985
Apr 16, 2026 43.82 44.30 43.20 43.96 43.96 901,898
Apr 15, 2026 43.76 44.42 43.27 43.90 43.90 840,764
Apr 14, 2026 43.32 44.15 43.09 43.68 43.68 811,319
Apr 13, 2026 41.55 43.46 41.48 43.30 43.30 1,261,584
Apr 10, 2026 42.34 42.81 41.45 41.91 41.91 843,275
Apr 9, 2026 41.73 42.84 41.00 42.25 42.25 925,447
Apr 8, 2026 42.44 43.45 41.68 41.87 41.87 1,607,269
Apr 7, 2026 40.36 41.90 40.36 41.69 41.69 1,091,222
Apr 6, 2026 42.16 42.94 40.79 40.85 40.85 1,022,117
Apr 2, 2026 40.95 43.37 40.48 42.49 42.49 1,498,233
Apr 1, 2026 40.61 42.59 40.60 41.98 41.98 1,945,037
Mar 31, 2026 38.73 40.35 38.50 40.31 40.31 1,509,227
Mar 30, 2026 37.81 39.00 37.47 38.12 38.12 1,956,434
Mar 27, 2026 38.09 38.44 37.15 37.60 37.60 1,775,510
Mar 26, 2026 38.76 40.12 37.88 38.53 38.53 3,033,310
Mar 25, 2026 34.15 50.40 33.99 40.47 40.47 11,743,399
Mar 24, 2026 33.17 34.11 33.00 33.82 33.82 1,242,456
Mar 23, 2026 35.00 35.27 33.61 33.63 33.63 1,338,954
Mar 20, 2026 35.50 36.35 34.46 34.64 34.64 3,205,427
Mar 19, 2026 32.95 34.25 32.89 34.08 34.08 1,266,430
Mar 18, 2026 33.01 33.49 32.68 33.30 33.30 1,654,087
Mar 17, 2026 32.41 33.68 32.23 33.51 33.51 1,038,555
Mar 16, 2026 32.36 32.85 32.04 32.18 32.18 725,319
Mar 13, 2026 32.77 33.12 31.81 32.15 32.15 1,019,057
Mar 12, 2026 33.22 33.43 31.95 32.39 32.39 1,154,428
Mar 11, 2026 33.47 34.27 33.00 33.74 33.74 1,239,018
Mar 10, 2026 34.00 34.00 32.93 33.54 33.54 1,018,337
Mar 9, 2026 33.57 34.11 33.10 33.99 33.99 1,208,763
Mar 6, 2026 33.26 34.18 32.99 33.87 33.87 1,230,034
Mar 5, 2026 34.94 35.55 33.85 34.04 34.04 1,330,893
Mar 4, 2026 35.28 36.05 34.93 35.69 35.69 1,082,134
Mar 3, 2026 34.92 35.73 33.99 35.28 35.28 1,397,589
Mar 2, 2026 34.56 36.27 34.34 35.97 35.97 1,134,415
Feb 27, 2026 35.21 35.74 34.57 35.70 35.70 1,408,954
Feb 26, 2026 36.47 36.47 34.50 35.78 35.78 1,576,919
Feb 25, 2026 37.65 38.22 33.94 36.22 36.22 2,985,780
Feb 24, 2026 35.40 37.58 35.40 36.48 36.48 1,972,294
Feb 23, 2026 34.61 35.78 34.21 35.34 35.34 1,673,756
Feb 20, 2026 33.97 35.06 33.29 34.82 34.82 2,560,109
Feb 19, 2026 39.65 40.28 28.66 34.24 34.24 11,764,635
Feb 18, 2026 39.48 40.51 39.15 39.82 39.82 807,980
Feb 17, 2026 39.90 40.41 39.41 39.63 39.63 840,225
Feb 13, 2026 39.11 40.43 39.09 39.97 39.97 684,520
Feb 12, 2026 40.85 40.85 38.00 38.34 38.34 1,367,964
Feb 11, 2026 40.59 41.00 39.66 40.83 40.83 851,688
Feb 10, 2026 41.28 41.92 40.82 40.97 40.97 591,841
Feb 9, 2026 40.77 41.41 40.30 41.31 41.31 858,038
Feb 6, 2026 39.01 40.85 38.68 40.83 40.83 1,384,511
Feb 5, 2026 39.90 40.75 38.10 38.36 38.36 1,063,705
Feb 4, 2026 41.02 41.36 39.42 40.13 40.13 1,297,706
Feb 3, 2026 40.54 41.28 39.74 40.70 40.70 1,752,377
Feb 2, 2026 39.87 42.26 39.63 40.71 40.71 2,250,828
Jan 30, 2026 37.39 40.72 36.80 39.87 39.87 5,067,528
Jan 29, 2026 45.74 46.09 44.34 44.61 44.61 1,785,866
Jan 28, 2026 46.26 47.06 45.24 45.85 45.85 1,668,724
Jan 27, 2026 45.53 46.29 43.52 46.22 46.22 1,751,071
Jan 26, 2026 43.21 45.67 42.90 45.63 45.63 1,839,075
Jan 23, 2026 41.77 44.84 41.41 43.98 43.98 3,946,512
Jan 22, 2026 41.51 43.50 40.46 41.30 41.30 5,899,136
Jan 21, 2026 35.29 37.50 35.00 36.31 36.31 1,436,295
Jan 20, 2026 34.11 35.31 33.80 35.29 35.29 1,632,798
Jan 16, 2026 35.39 35.85 34.54 34.73 34.73 2,416,137
Jan 15, 2026 37.00 37.22 35.16 35.39 35.39 1,351,827
Jan 14, 2026 36.10 37.48 35.71 37.04 37.04 1,284,947
Jan 13, 2026 37.35 37.46 36.23 36.35 36.35 1,239,340
Jan 12, 2026 37.44 38.11 37.00 37.36 37.36 1,326,019
Jan 9, 2026 36.95 37.70 36.20 37.50 37.50 1,613,160
Jan 8, 2026 36.50 37.50 36.13 36.53 36.53 1,863,731
Jan 7, 2026 36.30 37.65 35.60 37.00 37.00 1,851,794
Jan 6, 2026 34.84 36.90 34.28 35.78 35.78 3,841,957
Jan 5, 2026 38.14 38.17 34.89 34.95 34.95 5,194,678
Jan 2, 2026 35.76 38.44 35.12 38.20 38.20 6,702,901
Dec 31, 2025 38.89 39.00 32.99 34.80 34.80 20,304,995
Dec 30, 2025 79.75 79.75 69.91 70.19 70.19 2,382,684
Dec 29, 2025 82.32 82.98 79.67 79.82 79.82 914,121
Dec 26, 2025 83.41 83.70 82.13 82.65 82.65 342,928
Dec 24, 2025 82.01 84.48 81.97 83.59 83.59 313,924
Dec 23, 2025 84.40 85.16 80.38 81.99 81.99 1,524,540
Dec 22, 2025 84.37 85.28 83.05 85.11 85.11 792,768
Dec 19, 2025 82.51 85.34 81.26 83.76 83.76 2,270,290
Dec 18, 2025 82.28 83.37 81.01 81.54 81.54 1,208,635
Dec 17, 2025 81.19 82.98 79.02 82.28 82.28 1,092,787
Dec 16, 2025 86.02 86.58 78.07 81.12 81.12 2,633,754
Dec 15, 2025 88.74 89.00 87.11 87.30 87.30 942,068
Dec 12, 2025 87.23 88.73 86.13 87.99 87.99 1,029,149
Dec 11, 2025 85.33 87.50 85.06 87.13 87.13 942,339
Dec 10, 2025 83.65 85.99 82.72 85.31 85.31 653,923
Dec 9, 2025 82.57 84.92 81.31 83.15 83.15 887,738
Dec 8, 2025 87.19 87.19 82.61 82.98 82.98 883,660
Dec 5, 2025 85.27 86.39 83.59 86.11 86.11 644,185
Dec 4, 2025 84.35 85.84 83.06 84.66 84.66 992,250
Dec 3, 2025 81.04 84.47 80.83 83.67 83.67 724,528
Dec 2, 2025 79.78 81.76 78.19 80.76 80.76 1,149,208
Dec 1, 2025 78.17 80.14 77.55 79.78 79.78 900,021
Nov 28, 2025 79.60 80.03 78.63 79.40 79.40 201,501
Nov 26, 2025 80.28 81.30 79.25 79.80 79.80 761,220
Nov 25, 2025 78.59 81.41 78.39 80.28 80.28 545,143
Nov 24, 2025 77.47 78.74 77.01 77.71 77.71 475,989
Nov 21, 2025 75.10 78.98 74.93 77.29 77.29 542,953
Nov 20, 2025 77.26 78.99 74.83 75.05 75.05 771,553
Nov 19, 2025 75.67 76.23 73.92 76.10 76.10 433,148
Nov 18, 2025 74.04 75.93 73.79 75.11 75.11 471,036
Nov 17, 2025 75.32 76.80 74.70 75.12 75.12 551,976
Nov 14, 2025 74.12 76.62 74.12 75.54 75.54 373,726
Nov 13, 2025 77.54 77.98 75.11 75.75 75.75 460,706
Nov 12, 2025 79.29 79.89 78.16 78.39 78.39 598,019
Nov 11, 2025 75.42 79.40 75.28 79.01 79.01 492,383
Nov 10, 2025 70.77 76.48 70.74 75.49 75.49 1,254,042
Nov 7, 2025 73.06 74.03 71.52 73.72 73.72 646,922
Nov 6, 2025 76.53 76.74 73.03 73.06 73.06 724,245
Nov 5, 2025 67.00 77.02 67.00 76.65 76.65 1,021,999
Nov 4, 2025 72.58 73.69 69.68 71.10 71.10 1,130,153
Nov 3, 2025 73.06 74.27 70.50 74.17 74.17 712,451
Oct 31, 2025 72.97 74.22 72.47 73.47 73.47 686,770
Oct 30, 2025 72.21 73.98 71.59 72.26 72.26 577,643
Oct 29, 2025 72.03 73.09 70.97 72.05 72.05 551,281
Oct 28, 2025 72.56 72.81 70.89 71.56 71.56 571,728
Oct 27, 2025 73.37 74.77 72.25 72.56 72.56 713,790
Oct 24, 2025 73.59 74.42 72.33 72.52 72.52 456,331
Oct 23, 2025 73.16 73.85 71.66 72.98 72.98 552,725
Oct 22, 2025 76.17 76.49 72.84 73.65 73.65 706,278
Oct 21, 2025 78.13 78.26 75.38 75.39 75.39 739,437
Oct 20, 2025 79.71 80.29 77.91 78.60 78.60 1,322,482
Oct 17, 2025 78.63 80.23 76.44 78.69 78.69 1,331,235
Oct 16, 2025 78.38 79.58 76.34 79.47 79.47 1,211,792
Oct 15, 2025 72.33 80.46 72.33 76.81 76.81 1,385,428
Oct 14, 2025 71.30 73.65 69.43 72.12 72.12 951,753
Oct 13, 2025 75.17 76.84 70.64 71.53 71.53 1,171,344
Oct 10, 2025 87.54 87.54 73.12 73.96 73.96 2,282,250
Oct 9, 2025 88.57 90.26 88.07 88.36 88.36 693,042
Oct 8, 2025 91.00 91.00 85.61 88.43 88.43 1,061,040
Oct 7, 2025 89.83 90.32 89.06 90.32 90.32 1,145,200
Oct 6, 2025 88.34 90.71 88.15 89.85 89.85 815,246
Oct 3, 2025 86.59 88.69 85.80 88.15 88.15 843,151
Oct 2, 2025 84.50 85.60 83.90 85.48 85.48 490,921
Oct 1, 2025 83.07 85.91 82.65 84.25 84.25 796,104
Sep 30, 2025 85.50 85.50 83.04 83.11 83.11 526,146
Sep 29, 2025 84.13 84.72 83.44 83.90 83.90 595,444
Sep 26, 2025 83.81 84.89 82.78 83.87 83.87 482,975
Sep 25, 2025 83.38 84.24 81.99 82.73 82.73 705,559
Sep 24, 2025 83.35 84.70 81.40 83.84 83.84 1,108,129
Sep 23, 2025 80.03 84.50 79.78 83.32 83.32 950,864

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Corcept Therapeutics Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CORT, per a recent SEC DEF 14A filing. We estimate that the median employee at CORCEPT THERAPEUTICS INC is paid $245,044.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation